| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | UBA5 DHX36 KIF23 DDX12P ATP7A ATAD5 SMCHD1 ATP13A5 UBA3 KIF20B MYO5C DHX15 SMC3 ATAD2B MACF1 DHX32 DNAH8 | 2.38e-05 | 614 | 172 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DHX36 KIF23 DDX12P ATP7A ATAD5 SMCHD1 ATP13A5 KIF20B DHX15 SMC3 ATAD2B MACF1 DHX32 DNAH8 | 2.96e-05 | 441 | 172 | 14 | GO:0016887 |
| GeneOntologyCellularComponent | kinesin complex | 5.20e-05 | 49 | 173 | 5 | GO:0005871 | |
| GeneOntologyCellularComponent | acrosomal vesicle | SPATA31A3 IFT74 SPATA31A7 SPATA31A6 SPATA31A5 SPATA31A1 SSH2 VPS13B | 3.27e-04 | 206 | 173 | 8 | GO:0001669 |
| GeneOntologyCellularComponent | trans-Golgi network transport vesicle | 3.28e-04 | 40 | 173 | 4 | GO:0030140 | |
| Domain | DUF4599 | 3.17e-06 | 12 | 171 | 4 | PF15371 | |
| Domain | DUF4599 | 3.17e-06 | 12 | 171 | 4 | IPR027970 | |
| Domain | TMEM191C | 8.33e-05 | 2 | 171 | 2 | PF15194 | |
| Domain | TMEM191B/C | 8.33e-05 | 2 | 171 | 2 | IPR028186 | |
| Domain | Gamma_tubulin | 8.33e-05 | 2 | 171 | 2 | IPR002454 | |
| Domain | ZnF_DBF | 2.49e-04 | 3 | 171 | 2 | SM00586 | |
| Domain | ZF_DBF4 | 2.49e-04 | 3 | 171 | 2 | PS51265 | |
| Domain | Znf_DBF | 2.49e-04 | 3 | 171 | 2 | IPR006572 | |
| Domain | KINESIN_LIGHT | 2.49e-04 | 3 | 171 | 2 | PS01160 | |
| Domain | Kinesin_light_repeat | 2.49e-04 | 3 | 171 | 2 | IPR015792 | |
| Domain | zf-DBF | 2.49e-04 | 3 | 171 | 2 | PF07535 | |
| Domain | Bromodomain | 3.93e-04 | 38 | 171 | 4 | PF00439 | |
| Domain | DUF1605 | 4.67e-04 | 17 | 171 | 3 | IPR011709 | |
| Domain | OB_NTP_bind | 4.67e-04 | 17 | 171 | 3 | PF07717 | |
| Domain | Kinesin_light | 4.94e-04 | 4 | 171 | 2 | IPR002151 | |
| Domain | PTPLA | 4.94e-04 | 4 | 171 | 2 | PF04387 | |
| Domain | Tyr_Pase-like_PTPLA | 4.94e-04 | 4 | 171 | 2 | IPR007482 | |
| Domain | BROMODOMAIN_2 | 5.27e-04 | 41 | 171 | 4 | PS50014 | |
| Domain | HA2 | 5.56e-04 | 18 | 171 | 3 | SM00847 | |
| Domain | HA2 | 5.56e-04 | 18 | 171 | 3 | PF04408 | |
| Domain | Helicase-assoc_dom | 5.56e-04 | 18 | 171 | 3 | IPR007502 | |
| Domain | Bromodomain | 5.79e-04 | 42 | 171 | 4 | IPR001487 | |
| Domain | BROMO | 5.79e-04 | 42 | 171 | 4 | SM00297 | |
| Domain | - | 5.79e-04 | 42 | 171 | 4 | 1.20.920.10 | |
| Domain | Anaphylatoxin_comp_syst | 8.18e-04 | 5 | 171 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 8.18e-04 | 5 | 171 | 2 | IPR001840 | |
| Domain | SMC_hinge | 1.22e-03 | 6 | 171 | 2 | SM00968 | |
| Domain | Rab5-bind | 1.22e-03 | 6 | 171 | 2 | PF09311 | |
| Domain | SMC_hinge | 1.22e-03 | 6 | 171 | 2 | PF06470 | |
| Domain | Rabaptin_Rab5-bd_dom | 1.22e-03 | 6 | 171 | 2 | IPR015390 | |
| Domain | TPR_10 | 1.22e-03 | 6 | 171 | 2 | PF13374 | |
| Domain | SMC_hinge | 1.22e-03 | 6 | 171 | 2 | IPR010935 | |
| Pubmed | 1.82e-11 | 6 | 175 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 1.82e-11 | 6 | 175 | 5 | 25930072 | |
| Pubmed | TDRKH ZMYND11 UACA ARHGAP23 ARRDC4 ATAD5 WWP1 TRPS1 BRD3 BOD1L2 TUBG1 YEATS2 UTP25 ZNF592 MTIF2 EPC1 CIZ1 SMARCD1 MACF1 MMS19 BICRAL SIGLEC1 | 5.31e-08 | 1116 | 175 | 22 | 31753913 | |
| Pubmed | 8.04e-08 | 151 | 175 | 9 | 17043677 | ||
| Pubmed | 1.20e-07 | 24 | 175 | 5 | 32212159 | ||
| Pubmed | NRBP1 TUBG2 IFT74 TRPS1 KIAA0319L APBA1 NFKBID UBA3 TSC2 DNAAF9 SEC31B LRP1B DSCAML1 ARHGAP5 AP2A1 ZNF592 TRIM9 MTIF2 SENP6 MACF1 UTRN ZNF292 SOS2 | 1.45e-07 | 1285 | 175 | 23 | 35914814 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FAT4 HACD3 OBSCN TSC2 BRD3 DSCAML1 DOCK5 IGSF10 ARHGAP5 ZNF592 TRIM9 SRGAP3 ATAD2B AKAP13 UTRN ZNF582 | 1.11e-06 | 736 | 175 | 16 | 29676528 |
| Pubmed | Primary cilia dynamics instruct tissue patterning and repair of corneal endothelium. | 1.24e-06 | 5 | 175 | 3 | 21285373 | |
| Pubmed | 1.24e-06 | 5 | 175 | 3 | 25877302 | ||
| Pubmed | TACC2 SEC31B KIF20B SMC3 TET1 EPC1 KNDC1 ANKRD30A DCLRE1A MMS19 HACD1 CFAP46 | 1.45e-06 | 415 | 175 | 12 | 16385451 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | DHX36 KIF23 HACD3 ATAD5 SMCHD1 TACC2 PRPF6 KIF20B PWP1 DECR1 AP2A1 SMC3 BAZ1A NOC4L MACF1 MED17 | 1.66e-06 | 759 | 175 | 16 | 35915203 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZMYND11 KIF23 ATAD5 SMCHD1 BRD3 KIF20B SMC3 ZNF592 BAZ1A ATAD2B CIZ1 SENP6 CDK11B ZNF292 | 2.77e-06 | 608 | 175 | 14 | 36089195 |
| Pubmed | KIF23 ARHGAP23 HACD3 FASTKD1 HDX MPDZ PRPF6 DOCK5 ARHGAP5 AP2A1 SMC3 SRGAP3 AKAP13 UTRN CDCA5 FGD3 SOS2 | 4.27e-06 | 916 | 175 | 17 | 32203420 | |
| Pubmed | Mammalian RanBP1 regulates centrosome cohesion during mitosis. | 4.32e-06 | 7 | 175 | 3 | 12840069 | |
| Pubmed | 6.36e-06 | 255 | 175 | 9 | 15324660 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | KIF23 ANPEP UACA TUBG2 TRPS1 TACC2 PRPF6 TUBG1 DHX15 DECR1 AP2A1 SMC3 PARD6A INF2 CIZ1 SASS6 SMARCD1 CDCA5 VPS13B | 6.43e-06 | 1155 | 175 | 19 | 20360068 |
| Pubmed | 6.88e-06 | 8 | 175 | 3 | 26540106 | ||
| Pubmed | 6.88e-06 | 8 | 175 | 3 | 38086550 | ||
| Pubmed | KIF23 UACA SMCHD1 PRPF6 DHX15 PWP1 DECR1 AP2A1 UTP25 SMC3 INF2 BAZ1A MACF1 SSH2 | 7.06e-06 | 660 | 175 | 14 | 32780723 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NCOA6 KIF23 IFT74 RAB11FIP2 KLC2 MPDZ TSC2 AKAP9 TRIM9 PI4KB TET1 MACF1 AKAP13 SSH2 UTRN KLC1 | 8.14e-06 | 861 | 175 | 16 | 36931259 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | OBSCN KLC2 BRD3 PRPF6 NEB SPATA31A6 SMC3 ZNF592 C4A C4B CDK11B ZNF292 | 9.09e-06 | 497 | 175 | 12 | 36774506 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 9.13e-06 | 202 | 175 | 8 | 33005030 | |
| Pubmed | TDRKH ATP7A WDR7 KIAA0319L POMGNT1 TSC2 RTN1 HPS3 INF2 PI4KB FURIN VPS13B | 1.05e-05 | 504 | 175 | 12 | 34432599 | |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 10. | ZMYND11 TACC2 KIF20B SMC3 TET1 EPC1 ANKRD30A DCLRE1A MMS19 CFAP46 | 1.09e-05 | 345 | 175 | 10 | 15164054 |
| Pubmed | 1.46e-05 | 10 | 175 | 3 | 16043481 | ||
| Pubmed | BAG5 RAB11FIP2 KLC2 MPDZ TSC2 AKAP9 AP2A1 SMC3 PI4KB SMARCD1 UTRN | 1.78e-05 | 446 | 175 | 11 | 24255178 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | DHX36 ATAD5 SMCHD1 PRPF6 KIF20B AP2A1 BAZ1A NOC4L CDK11B HNRNPLL | 1.99e-05 | 370 | 175 | 10 | 22922362 |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 2.52e-05 | 2 | 175 | 2 | 16565498 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 15998580 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 2.52e-05 | 2 | 175 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 2.52e-05 | 2 | 175 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 2.52e-05 | 2 | 175 | 2 | 17645767 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 2.52e-05 | 2 | 175 | 2 | 27758680 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 22387014 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 2.52e-05 | 2 | 175 | 2 | 23749435 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 2.52e-05 | 2 | 175 | 2 | 3037333 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 11726230 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 2.52e-05 | 2 | 175 | 2 | 6950384 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 2.52e-05 | 2 | 175 | 2 | 8428773 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 2.52e-05 | 2 | 175 | 2 | 21345967 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 2572548 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 2302180 | ||
| Pubmed | MTOC reorientation occurs during FcgammaR-mediated phagocytosis in macrophages. | 2.52e-05 | 2 | 175 | 2 | 17442887 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 2.52e-05 | 2 | 175 | 2 | 18091514 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 29080553 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 2.52e-05 | 2 | 175 | 2 | 25339671 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 17728371 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 6149580 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 6149581 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 12115608 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 3542363 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 2387317 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 22806905 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 16908004 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 7365238 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 7391573 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 17971360 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 22470497 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 2.52e-05 | 2 | 175 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 2.52e-05 | 2 | 175 | 2 | 17971229 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 6881182 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 2.52e-05 | 2 | 175 | 2 | 17921792 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 2.52e-05 | 2 | 175 | 2 | 6978711 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 35898513 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 28873507 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 2.52e-05 | 2 | 175 | 2 | 6832377 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 3794341 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 17287496 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 22785613 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 2.52e-05 | 2 | 175 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 2.52e-05 | 2 | 175 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 2.52e-05 | 2 | 175 | 2 | 7373044 | |
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 2.52e-05 | 2 | 175 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 2.52e-05 | 2 | 175 | 2 | 1357031 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 28119396 | ||
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 2.52e-05 | 2 | 175 | 2 | 16098595 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 2.52e-05 | 2 | 175 | 2 | 15787745 | |
| Pubmed | Structural plasticity of the N-terminal capping helix of the TPR domain of kinesin light chain. | 2.52e-05 | 2 | 175 | 2 | 29036226 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 30026462 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 6559257 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 2.52e-05 | 2 | 175 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 2.52e-05 | 2 | 175 | 2 | 20506482 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 12480675 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 26800705 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 2.52e-05 | 2 | 175 | 2 | 15390104 | |
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 2.52e-05 | 2 | 175 | 2 | 1699796 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 2.52e-05 | 2 | 175 | 2 | 2997024 | |
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 2.52e-05 | 2 | 175 | 2 | 3624865 | |
| GeneFamily | Zinc fingers DBF-type | 1.26e-04 | 3 | 118 | 2 | 75 | |
| GeneFamily | DEAH-box helicases | 1.43e-04 | 16 | 118 | 3 | 500 | |
| GeneFamily | PDZ domain containing | 4.86e-04 | 152 | 118 | 6 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 6.37e-04 | 160 | 118 | 6 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.58e-04 | 161 | 118 | 6 | 593 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.10e-04 | 66 | 118 | 4 | 722 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.48e-03 | 9 | 118 | 2 | 1234 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 1.79e-03 | 37 | 118 | 3 | 454 | |
| GeneFamily | Ubiquitin like modifier activating enzymes | 1.84e-03 | 10 | 118 | 2 | 100 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 4.25e-03 | 50 | 118 | 3 | 721 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZMYND11 KIF23 WDR7 WWP1 SMCHD1 KIF20B DHX15 KIFAP3 AKAP9 SMC3 BAZ1A DBF4 MTIF2 ATAD2B MACF1 AKAP13 BICRAL VPS13B KLC1 ZNF292 SOS2 | 2.49e-07 | 856 | 173 | 21 | M4500 |
| Coexpression | GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN | 6.83e-06 | 197 | 173 | 9 | M8464 | |
| Coexpression | GSE27786_CD8_TCELL_VS_NEUTROPHIL_DN | ZMYND11 ARHGAP23 ARRDC4 TSC2 DNAAF9 KNDC1 SASS6 HNRNPLL SOS2 | 7.41e-06 | 199 | 173 | 9 | M4847 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 7.41e-06 | 199 | 173 | 9 | M5893 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN | 7.72e-06 | 200 | 173 | 9 | M10033 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | NCOA6 ZMYND11 IFT74 FASTKD1 TRPS1 CARS1 ADCK2 UBA3 LAMP2 PRPF6 PTP4A1 PWP1 DECR1 ST3GAL6 UTP25 BAZ1A DBF4 ATAD2B CIZ1 SENP6 MACF1 SOS2 | 1.78e-05 | 1215 | 173 | 22 | M41122 |
| Coexpression | LIU_SOX4_TARGETS_DN | NCOA6 KIAA0319L CARS1 ADGRG1 PSPH DECR1 PMPCA SMC3 INF2 MMS19 | 4.31e-05 | 310 | 173 | 10 | M17287 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | UBA5 SYNPO2 KIF23 HACD3 FASTKD1 POMGNT1 LAMP2 ZDBF2 DNAAF9 PSPH KIF20B DHX15 PWP1 YEATS2 CAMKK2 UTP25 DBF4 TET1 SENP6 SASS6 SIGLEC1 CDCA5 HNRNPLL | 5.55e-05 | 1407 | 173 | 23 | M14427 |
| Coexpression | GSE27786_ERYTHROBLAST_VS_MONO_MAC_UP | 5.76e-05 | 200 | 173 | 8 | M4877 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP | 5.76e-05 | 200 | 173 | 8 | M4440 | |
| Coexpression | ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN | 7.49e-05 | 106 | 173 | 6 | M9160 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | DHX36 ATAD5 IFT74 TRPS1 KLC2 ADGRG1 ZDBF2 ACVR1C RTN1 KIF20B TUBG1 HPS3 ARHGAP5 IARS2 AKAP9 SMC3 BAZ1A SRGAP3 DBF4 MTIF2 ATAD2B SASS6 MACF1 DHX32 CDK11B FGD3 ZNF292 | 1.36e-07 | 1060 | 173 | 27 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | DHX36 ATAD5 IFT74 TRPS1 KLC2 ADGRG1 ZDBF2 ACVR1C RTN1 DSCAML1 KIF20B TUBG1 HPS3 MYO5C ARHGAP5 IARS2 AKAP9 SMC3 BAZ1A SRGAP3 DBF4 MTIF2 ATAD2B SASS6 MACF1 DHX32 CDK11B FGD3 ZNF292 KCNH5 | 1.24e-06 | 1414 | 173 | 30 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | DHX36 NCOA6 ATAD5 IFT74 PRPF6 KIF20B AKAP9 SMC3 BAZ1A MTIF2 ATAD2B CDK11B ZNF292 | 1.72e-06 | 311 | 173 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | DHX36 NCOA6 ATAD5 IFT74 SMCHD1 TRPS1 ZDBF2 PRPF6 ACVR1C KIF20B TUBG1 ARHGAP5 IARS2 AKAP9 SMC3 BAZ1A DBF4 MTIF2 PI4KB ATAD2B TET1 SASS6 MACF1 DHX32 CDK11B CPLANE1 ZNF292 | 3.64e-06 | 1257 | 173 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | ATAD5 BAG5 TRPS1 CAPN6 MPDZ ADGRG1 PRPF6 KIF20B ARHGAP5 AKAP9 SMC3 BAZ1A PDE8B MTIF2 ATAD2B TET1 KNDC1 MACF1 MMS19 CDK11B MED17 ZNF292 | 1.87e-05 | 989 | 173 | 22 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | DHX36 NCOA6 ATAD5 IFT74 SMCHD1 TRPS1 ZDBF2 PRPF6 ACVR1C RTN1 KIF20B TUBG1 ARHGAP5 IARS2 AKAP9 SMC3 BAZ1A DBF4 MTIF2 PI4KB ATAD2B TET1 SASS6 MACF1 DHX32 CDK11B CPLANE1 ZNF292 | 1.93e-05 | 1459 | 173 | 28 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 2.15e-05 | 232 | 173 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.90e-05 | 192 | 173 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | DHX36 NCOA6 ATAD5 IFT74 TRPS1 CAPN6 KLC2 ADGRG1 PRPF6 KIF20B TUBG1 HPS3 IGSF10 ARHGAP5 IARS2 AKAP9 SMC3 BAZ1A DBF4 PI4KB ATAD2B TET1 CDK11B CPLANE1 ZNF292 | 2.98e-05 | 1252 | 173 | 25 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | KIF23 UACA ATAD5 WWP1 KIF20B AKAP9 UTP25 SMC3 BAZ1A SUSD5 TET1 LRRC8A CDK11B ZNF292 | 3.19e-05 | 469 | 173 | 14 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | TDRKH ATAD5 ZDBF2 RTN1 AKAP9 SMC3 BAZ1A SRGAP3 DHX32 CDK11B ZNF292 | 3.48e-05 | 298 | 173 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | DHX36 NCOA6 TDRKH ATAD5 IFT74 ZDBF2 PRPF6 KIF20B TUBG1 AKAP9 SMC3 BAZ1A TRIM9 DBF4 MTIF2 EPC1 DHX32 CDK11B ZNF292 | 5.02e-05 | 831 | 173 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | TDRKH NR2F6 SYNPO2 ATAD5 TRPS1 ADGRG1 ZDBF2 DNAAF9 RTN1 KIF20B CSDC2 AKAP9 SMC3 BAZ1A SRGAP3 PDE8B ATAD2B MACF1 DHX32 CDK11B ZNF292 | 5.52e-05 | 986 | 173 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | ATAD5 TRPS1 CAPN6 PRPF6 KIF20B ARHGAP5 SMC3 BAZ1A ATAD2B TET1 MACF1 CDK11B ZNF292 | 5.66e-05 | 432 | 173 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | DHX36 NCOA6 TDRKH ATAD5 IFT74 ADGRG1 ZDBF2 PRPF6 RTN1 KIF20B AKAP9 SMC3 BAZ1A TRIM9 SRGAP3 DBF4 MTIF2 ATAD2B DHX32 CDK11B ZNF292 | 5.76e-05 | 989 | 173 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ATAD5 BAG5 PEX12 PRPF6 KIF20B ARHGAP5 AKAP9 SMC3 BAZ1A PDE8B MTIF2 ATAD2B TET1 MACF1 CDK11B ZNF292 | 5.93e-05 | 629 | 173 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | TDRKH ATAD5 ADGRG1 ZDBF2 PRPF6 RTN1 KIF20B AKAP9 SMC3 BAZ1A TRIM9 SRGAP3 MTIF2 CDK11B | 6.09e-05 | 498 | 173 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.91e-05 | 173 | 173 | 8 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | TDRKH SMCHD1 BAG5 PEX12 ZDBF2 PRPF6 ARHGAP5 MTIF2 ATAD2B SENP6 MACF1 DHX32 CDK11B HNRNPLL ZNF292 | 1.12e-04 | 595 | 173 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | NCOA6 TRPS1 PRPF6 KIF20B AKAP9 BAZ1A ATAD2B MACF1 CDK11B CPLANE1 | 1.43e-04 | 291 | 173 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.47e-04 | 186 | 173 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | SYNPO2 TRPS1 ADGRG1 ZDBF2 PRPF6 KIF20B SYT15 AKAP9 BAZ1A ATAD2B KNDC1 MACF1 CDK11B | 2.06e-04 | 492 | 173 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.32e-04 | 166 | 173 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K1 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.07e-08 | 197 | 175 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.03e-07 | 200 | 175 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-07 | 173 | 175 | 8 | 63f03abca84ae021ff34ff34537838aa8a1ccd11 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 5.66e-07 | 179 | 175 | 8 | 83506e00fe99b6450efd2f13f716926a0a4b03cd | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.98e-07 | 193 | 175 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 1.26e-06 | 199 | 175 | 8 | fa698f00d2dad74d28b4696c8c23dce70f123e52 | |
| ToppCell | erythropoietic-Polychromatic_Erythroblast|erythropoietic / Lineage and Cell class | 1.30e-06 | 200 | 175 | 8 | 27056f28328df2a51d5634a7927b7084241e3ca2 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-06 | 167 | 175 | 7 | e30e7ac8ea4399dc3c1d94fc6b857afc80a7a671 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-06 | 170 | 175 | 7 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-06 | 170 | 175 | 7 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-06 | 171 | 175 | 7 | 25493a4a7b636920e2cfd984542cc500709c9dcf | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-06 | 171 | 175 | 7 | 508b41e3ad2638f9dd546d251b13ff60fc8c3207 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.16e-06 | 183 | 175 | 7 | 310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.16e-06 | 183 | 175 | 7 | fef51dcf180e6d4e136362c7e140ec5ef372e6d0 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 8.76e-06 | 185 | 175 | 7 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.76e-06 | 185 | 175 | 7 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.76e-06 | 185 | 175 | 7 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 9.39e-06 | 187 | 175 | 7 | 3c10b8501226c69d71bcd99dc1c064a3c2154f87 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.12e-05 | 192 | 175 | 7 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | MS-Treg-exh_CD4|MS / Condition, Cell_class and T cell subcluster | 1.12e-05 | 192 | 175 | 7 | c6722bf142c84ccedd99c1a3344085aecb4cbab4 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.23e-05 | 195 | 175 | 7 | 80b973d2a23ef9b101c90e1635e68c9a3f78f65d | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.32e-05 | 197 | 175 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.36e-05 | 198 | 175 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.36e-05 | 198 | 175 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-05 | 198 | 175 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.41e-05 | 199 | 175 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.41e-05 | 199 | 175 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Transverse-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 1.41e-05 | 199 | 175 | 7 | 170ae68963d31f3b821b6f0e8f0c039bea0bc981 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells-Neuroepithelial_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.45e-05 | 200 | 175 | 7 | c88d8e67647c90d1fa2569516865a9fd766eaf1c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.45e-05 | 200 | 175 | 7 | 28935053cd6918cd2e9f3e7691f8522216585cb6 | |
| ToppCell | metastatic_Brain-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 3.31e-05 | 154 | 175 | 6 | 423f58fc7dcef068458cbf7b4ee989e37227041e | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 159 | 175 | 6 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 159 | 175 | 6 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.25e-05 | 161 | 175 | 6 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | facs-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 161 | 175 | 6 | 45591addc765760db6029ac19e80573373d1d917 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 161 | 175 | 6 | 8741b91a62c9a8ce377ef6533d323b65beb93c63 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 161 | 175 | 6 | 9cf1dcf0e7ca9e35c46c094a6b78f98d1f6b9276 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 162 | 175 | 6 | 3fd6aaf0fbaffc7ab38aa25e46c37ef511e1e704 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 162 | 175 | 6 | 8134f73eb76693f4f1845f643042fdc1e81c274c | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.04e-05 | 166 | 175 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-05 | 171 | 175 | 6 | 355a27ea88410a84210f7e4298c7c4f90cf2f8a9 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.94e-05 | 171 | 175 | 6 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.19e-05 | 177 | 175 | 6 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.19e-05 | 177 | 175 | 6 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.89e-05 | 180 | 175 | 6 | 551b8de8d933d11bcd3897aeb2fd033355f958e2 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.64e-05 | 183 | 175 | 6 | a716b446c2bf5aa294b8f580aa845098fae76354 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 8.90e-05 | 184 | 175 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.73e-05 | 187 | 175 | 6 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 188 | 175 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 188 | 175 | 6 | 40ce7125fca6f6b6b5cc1637c87d43c29b08f4f1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 188 | 175 | 6 | ba7f7ce034c0f42742bf2461f68f8d343ee593a5 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 189 | 175 | 6 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-04 | 189 | 175 | 6 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.03e-04 | 189 | 175 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 189 | 175 | 6 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-04 | 189 | 175 | 6 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 189 | 175 | 6 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 189 | 175 | 6 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.06e-04 | 190 | 175 | 6 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.06e-04 | 190 | 175 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 191 | 175 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 1.09e-04 | 191 | 175 | 6 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.09e-04 | 191 | 175 | 6 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 191 | 175 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.16e-04 | 193 | 175 | 6 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 194 | 175 | 6 | c8b9551b93a5aed62154b487db90130604a6125c | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.19e-04 | 194 | 175 | 6 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-04 | 194 | 175 | 6 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 195 | 175 | 6 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-04 | 196 | 175 | 6 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 196 | 175 | 6 | 81900dcc9451ff6606ec940c16b559d73247590e | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.29e-04 | 197 | 175 | 6 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 197 | 175 | 6 | d584d0334ea97e3fa8c4cd869f5eeea2c7a1ed04 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 197 | 175 | 6 | 412091994196a06c2779b4c2cfed84be889a5f8d | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.33e-04 | 198 | 175 | 6 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 1.37e-04 | 199 | 175 | 6 | 5c8b847b794b3e88722f5b841f2539a27251106c | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.37e-04 | 199 | 175 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.37e-04 | 199 | 175 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.37e-04 | 199 | 175 | 6 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.37e-04 | 199 | 175 | 6 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.37e-04 | 199 | 175 | 6 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.37e-04 | 199 | 175 | 6 | c7c501ad144ac5488d0b0496554d46616f2e01a6 | |
| ToppCell | mild-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.40e-04 | 200 | 175 | 6 | 86f585bf9066b179bbcbc703bf43f15da4a07284 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.40e-04 | 200 | 175 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.40e-04 | 200 | 175 | 6 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.40e-04 | 200 | 175 | 6 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.40e-04 | 200 | 175 | 6 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-T/NK_proliferative|ICU-NoSEP / Disease, condition lineage and cell class | 1.40e-04 | 200 | 175 | 6 | f70cc9198339eab7fbc68f5d9b75dfb28c9afc89 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.40e-04 | 200 | 175 | 6 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-NoSEP / Disease, Lineage and Cell Type | 1.40e-04 | 200 | 175 | 6 | d86119766b9c4f1570cd8045313345f9be46d431 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.40e-04 | 200 | 175 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-04 | 200 | 175 | 6 | a372ef3f9e6ff6e3c3376d6e10182977c5067788 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.63e-04 | 130 | 175 | 5 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.94e-04 | 135 | 175 | 5 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.15e-04 | 49 | 106 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.26e-04 | 50 | 106 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; PC3; HG-U133A | B3GALNT1 WWP1 SMCHD1 RAB11FIP2 PSPH ARHGAP5 UTP25 BAZ1A CIZ1 MED17 | 2.52e-06 | 197 | 171 | 10 | 1930_DN |
| Drug | Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | KIAA0319L MFAP3L CSF1R AKAP9 FURIN ATAD2B AKAP13 DCLRE1A PRKD1 SOS2 | 2.64e-06 | 198 | 171 | 10 | 7261_UP |
| Drug | Amoxapine [14028-44-5]; Down 200; 12.8uM; HL60; HG-U133A | NRBP1 WDR7 PEX12 MLYCD MYO5C KIFAP3 ATAD2B MACF1 AKAP13 KLC1 | 2.64e-06 | 198 | 171 | 10 | 2013_DN |
| Disease | ACUTE ALCOHOL WITHDRAWAL | 3.18e-05 | 2 | 167 | 2 | C0149821 | |
| Disease | complex cortical dysplasia with other brain malformations 4 (implicated_via_orthology) | 3.18e-05 | 2 | 167 | 2 | DOID:0090138 (implicated_via_orthology) | |
| Disease | Ciliopathies | 3.96e-05 | 110 | 167 | 6 | C4277690 | |
| Disease | macrophage colony-stimulating factor 1 receptor measurement | 4.71e-04 | 6 | 167 | 2 | EFO_0020547 | |
| Disease | Microcephaly | 5.75e-04 | 67 | 167 | 4 | C0025958 | |
| Disease | Alzheimer's disease 1 (implicated_via_orthology) | 6.56e-04 | 7 | 167 | 2 | DOID:0080348 (implicated_via_orthology) | |
| Disease | Nemaline myopathy | 8.72e-04 | 8 | 167 | 2 | cv:C0206157 | |
| Disease | disease recurrence, malaria | 8.72e-04 | 8 | 167 | 2 | EFO_0001068, EFO_0004952 | |
| Disease | Intellectual Disability | 1.06e-03 | 447 | 167 | 9 | C3714756 | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 1.12e-03 | 9 | 167 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | diverticulitis | 1.20e-03 | 37 | 167 | 3 | EFO_1001460 | |
| Disease | sexual dysfunction | 1.69e-03 | 11 | 167 | 2 | EFO_0004714 | |
| Disease | body fat percentage | 1.93e-03 | 488 | 167 | 9 | EFO_0007800 | |
| Disease | Congenital myopathy (disorder) | 2.02e-03 | 12 | 167 | 2 | C0270960 | |
| Disease | Alzheimer disease, dementia, family history of Alzheimer’s disease | 2.55e-03 | 48 | 167 | 3 | EFO_0009268, MONDO_0001627, MONDO_0004975 | |
| Disease | nose morphology measurement | 2.79e-03 | 329 | 167 | 7 | EFO_0007843 | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 3.04e-03 | 51 | 167 | 3 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | Tremor, Rubral | 3.63e-03 | 16 | 167 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 3.63e-03 | 16 | 167 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 3.63e-03 | 16 | 167 | 2 | C0278161 | |
| Disease | intracerebral hemorrhage | 3.63e-03 | 16 | 167 | 2 | EFO_0005669 | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to anticonvulsant | 3.63e-03 | 16 | 167 | 2 | EFO_0004276, EFO_0004775, GO_0036277 | |
| Disease | Ataxia, Sensory | 3.63e-03 | 16 | 167 | 2 | C0240991 | |
| Disease | Abnormal coordination | 3.63e-03 | 16 | 167 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 3.63e-03 | 16 | 167 | 2 | C0427190 | |
| Disease | stroke outcome severity measurement | 4.08e-03 | 114 | 167 | 4 | EFO_0009603 | |
| Disease | lateral occipital cortex volume measurement | 4.10e-03 | 17 | 167 | 2 | EFO_0010311 | |
| Disease | mean corpuscular hemoglobin concentration | HACD3 TSC2 BRD3 NEB GFUS SYT15 BAZ1A ATAD2B MACF1 AKAP13 DHX32 PARP9 MED17 VPS13B | 4.20e-03 | 1105 | 167 | 14 | EFO_0004528 |
| Disease | granulocyte percentage of myeloid white cells | 4.33e-03 | 268 | 167 | 6 | EFO_0007997 | |
| Disease | Feeding difficulties | 4.59e-03 | 18 | 167 | 2 | C0232466 | |
| Disease | anorectal malformation | 5.11e-03 | 19 | 167 | 2 | MONDO_0019938 | |
| Disease | Acute Myeloid Leukemia, M1 | 5.64e-03 | 125 | 167 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 5.64e-03 | 125 | 167 | 4 | C1879321 | |
| Disease | Familial aplasia of the vermis | 5.66e-03 | 20 | 167 | 2 | cv:C0431399 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QVRFKTVTVLAQVHP | 316 | Q96QE3 | |
| IIPITNSSQFKHQEA | 301 | Q9H2F5 | |
| KAVHEQLAALSQAPV | 471 | Q15059 | |
| IPENSVNVAIDHLSK | 2446 | Q99996 | |
| EATNLISVAVKVLHP | 301 | Q7Z695 | |
| KRIVAHAVEVPAVQS | 61 | Q96FF9 | |
| VADRHSVINQALIKP | 111 | Q4VNC0 | |
| QHPSISRLQEIQKEV | 6 | Q9UL15 | |
| KNLTVSVHVSPVEGL | 861 | P0C0L5 | |
| VDRISSQVVDPKLNH | 116 | Q8IYS8 | |
| RINITVSDVNDHTPK | 1826 | Q6V0I7 | |
| VKHDSILNTIDIPQN | 346 | Q8NER5 | |
| EHNKEVAPQVSLLTQ | 996 | Q12802 | |
| QIVTSRKSQEPAFHI | 1211 | Q9BXX3 | |
| VHPGDLQTQLAVQTK | 796 | O95782 | |
| HSTVQPEVADKIVLV | 2316 | Q8IYW2 | |
| KIQTQLQRDHSAIPV | 641 | P15144 | |
| INTILKAQHPNIVTV | 486 | P21127 | |
| LTVKDNQVVQLHPST | 711 | O43143 | |
| SKDILQQVVDHLSPV | 706 | Q7L7V1 | |
| QVPKVSDQALVSAHS | 106 | Q5HYR2 | |
| INSSQEHLTVQAKAP | 536 | Q9UBU7 | |
| QKLGLHVTPSNVDQV | 1531 | Q9NRL2 | |
| VPDQSVKRELQVVSH | 151 | Q8NCT1 | |
| HGTPVVNQVKVLTES | 1051 | Q04656 | |
| PAHVESLQEKAQVAL | 321 | P10588 | |
| VSKQHSVVPSQIFEL | 406 | Q8WVV9 | |
| HDITVGPVAKSILQQ | 341 | Q8IXQ6 | |
| KVLDVNDNIPSIHVT | 341 | Q9NPG4 | |
| SKLPQVVTDVGVHLQ | 556 | Q8IWT6 | |
| VVTDVGVHLQKLSIN | 561 | Q8IWT6 | |
| AEVTKLQQLSSHAVP | 211 | P57723 | |
| HDPTSENILQLVKAA | 106 | Q15139 | |
| SSLHEQPQQIAIKVS | 306 | O75121 | |
| TDTQITEAHKIPIQK | 126 | Q7Z353 | |
| TATKNDTEFQLHIPV | 141 | Q7Z353 | |
| KVVHNTAVPNALAVD | 3081 | Q9NZR2 | |
| PAISITENVLHFKAQ | 31 | Q9P035 | |
| ESIQHAKDAQVPIIL | 271 | P46199 | |
| SNKTVLHLAVQAANP | 206 | Q8NI38 | |
| VTPIVTQHSKVNDSN | 196 | Q8IZA0 | |
| LKAIFQEVHVQSLPQ | 131 | Q96T76 | |
| LAVLQKVFPHAEISQ | 691 | Q9ULI0 | |
| IPEQALQTTLQEVKH | 901 | Q8NCM2 | |
| QDFSQKSHLPSIVVE | 76 | Q9BQE6 | |
| VILVTSHPSDVKARQ | 81 | O75752 | |
| ISSNIQAIVKEHPPS | 261 | O95822 | |
| SGDSIQQHVKITPVI | 351 | O95263 | |
| PNVSHNVALKVSVQS | 201 | Q32MH5 | |
| SFIKSEVHLAIPNVV | 881 | Q96JB1 | |
| VHILDSQTVVLKEPQ | 81 | Q96Q89 | |
| DKVASVININPNTTH | 246 | P13473 | |
| TAQTRALFEKVQPTH | 51 | Q13630 | |
| ENVVLPQIHTVTGTK | 1226 | P00451 | |
| ASLSNQVPKNHVSLV | 341 | Q2TBA0 | |
| LSREAVQIKSQVPHI | 311 | Q9NVC6 | |
| VQDIVKPNTAHTFII | 426 | Q5JSP0 | |
| LKTAFPSVQINTEEH | 121 | Q9NX62 | |
| PVDHAQSESILKVSQ | 396 | Q27J81 | |
| SQVVPQGISVKHLDA | 3051 | Q9UPN3 | |
| KDHPAVAATLNNLAV | 276 | Q9H0B6 | |
| IKIGSVAPDTINNHV | 216 | Q9UHY1 | |
| VVSALPQRAENKLHV | 5866 | Q5VST9 | |
| VANSHNLIVTVKPAN | 236 | Q9NPB6 | |
| NFATPQTHKLDSVVV | 1296 | Q14686 | |
| NTVSELIKVAGHPNI | 126 | Q16698 | |
| EVLSQEPFHKVTVQS | 456 | P07333 | |
| HNAKPQQLVAEVATS | 1511 | Q6WRI0 | |
| QQLVAEVATSPKVHP | 1516 | Q6WRI0 | |
| LSSQIKVAHRPVTQQ | 61 | Q96LB3 | |
| ASKNPDLIEVQNHII | 71 | A2RU49 | |
| VPNHIVVSAEGNISK | 881 | Q6AI39 | |
| HVIGENEPLTSVLNK | 371 | Q9H7D0 | |
| QPVKTAGEITQHNVT | 301 | Q8N9W5 | |
| PLQHSKVASVVRDQN | 981 | Q9H799 | |
| DHEKLSQNTLPVIGV | 1526 | Q9H799 | |
| NVIKQQSDHLAVPSS | 2616 | Q9H799 | |
| PQLSISQSVHVAVKV | 581 | Q8TD84 | |
| PAIISAALQQVVHNK | 986 | Q5JV73 | |
| LVVQTSKPAHLNAND | 396 | P09958 | |
| LVAVHPKSVNVEQTD | 866 | Q9H2U1 | |
| THSIKPIQNEESVVL | 156 | B0YJ81 | |
| RIASVAVQQIEKIHP | 556 | Q53R41 | |
| QEPKSAHQVEQVLLA | 756 | Q92771 | |
| VVQALQTHPDSNVKA | 836 | Q5TEA3 | |
| KVANLTEPVVLTFQH | 321 | Q9Y653 | |
| INGQSVVATPHEKIV | 791 | Q02410 | |
| APITTDLAHIQKAAT | 231 | A2RUH7 | |
| VENSVKHIPSLATVI | 471 | Q96RR4 | |
| PNKDVQAVASVHTLA | 406 | Q8NFN8 | |
| TSEATHFKPIVLAQN | 671 | Q76NI1 | |
| QPVHTVILEALNKFV | 351 | Q9UJ99 | |
| HSNKFTRIADVIPQT | 966 | Q6PJP8 | |
| KFQAVEVVLTQLAPH | 126 | Q9Y534 | |
| RSPVQKNTVHAIFDT | 551 | Q9Y6Q1 | |
| ELQSVSNPVHRKDLV | 31 | Q6UVJ0 | |
| HPEVSKAASVINQAL | 446 | Q9BVI4 | |
| KNLTVSVHVSPVEGL | 861 | P0C0L4 | |
| HQATRDVIIKETQAP | 621 | Q92845 | |
| KDHPAVAATLNNLAV | 291 | Q07866 | |
| THTTQKELFDVVANP | 81 | Q02241 | |
| NIRIEKPVQEAHSTL | 546 | O14829 | |
| ILQKENGHVTISESP | 126 | Q16799 | |
| PTENVAKINREVLHS | 226 | Q10713 | |
| KAIQAVATNPKTTHE | 201 | Q68CQ4 | |
| SVSQTRIAAHPNVQK | 2191 | P46939 | |
| RIAAHPNVQKVVLVS | 2196 | P46939 | |
| TILPIDQVKTSHVEN | 36 | Q9C004 | |
| EILTVNTVKQTPNHI | 496 | O60279 | |
| TQVDEVKSIPANSHL | 126 | Q8IWZ5 | |
| VGLIKAQHLQAPSET | 166 | Q9BQS2 | |
| DQTIVDPFSSKHNVI | 16 | Q9UQE7 | |
| ALRKVQEQVHPTLSA | 26 | Q07890 | |
| ELKIHNIDIPTTQQV | 1671 | A6NHR9 | |
| QHAVQLATEPLEKAV | 156 | P49589 | |
| IIINHVISVDPNDQK | 371 | Q96GM5 | |
| QTVVLQVRPHSDAKV | 216 | P0C7N4 | |
| EQTVVLQVRPHSDAK | 216 | A6NGB0 | |
| EKSQQAVLTPQFLHV | 371 | Q969F9 | |
| LEKQVPVHSVFSQSE | 201 | Q92901 | |
| LAVNQALPVSNTHVK | 751 | Q5VVP1 | |
| DTAKAVVAQAVRHLP | 356 | O94906 | |
| QNNPVSTVKAILHDV | 546 | Q7RTY7 | |
| IQHTPISIKNARVSQ | 356 | Q8WZA1 | |
| APVNVTVRHLKANSA | 36 | Q8NAU1 | |
| AVNQALPVSNTHVKT | 756 | Q8IWB4 | |
| IHNDPNTTVILTAFK | 176 | Q9Y274 | |
| VVVAPFKEISIHLTN | 586 | Q8WX94 | |
| SKSLGNVIHPDVVVN | 666 | Q9NSE4 | |
| SVKHNLDVVSPIPAN | 756 | Q13017 | |
| NVTHILSSGKEPVIA | 101 | Q9NQW1 | |
| ALQHVVKVLAESNPT | 36 | O00623 | |
| VPHTQAVVLNSKDKA | 381 | Q9UBF8 | |
| QTKNIVPHDQVDATL | 201 | Q96DW6 | |
| LPNIQVFASHIDKSA | 306 | O00463 | |
| VQLTVNANQKAHPLT | 1286 | Q8NFU7 | |
| KAIPVSIHVNVILFS | 91 | P58418 | |
| SKNHTLPAVEVQSAI | 91 | Q9HBJ8 | |
| LQKQAQTQTSPEHLV | 341 | Q9ULV3 | |
| AVNQALPVSNTHVKT | 756 | Q5VYP0 | |
| PAASLAVHTDKVQTL | 291 | Q13610 | |
| VADVTTPQTVLFKLH | 446 | Q8TBC4 | |
| AQQPVLVSQTLDIHK | 1016 | Q9UHF7 | |
| DRIVHINSIPTNEKA | 236 | Q9UMS6 | |
| AKAAIHQILTENTPV | 111 | Q9Y2W6 | |
| VKLTIHAENPDSQAV | 1556 | O75970 | |
| VEHVASKLNIPATNV | 116 | P78330 | |
| AVNQALPVSNTHVKT | 756 | Q5TZJ5 | |
| STDNRVHIFKPVSVQ | 161 | Q76I76 | |
| ISTIKLENPAERVHQ | 601 | O43295 | |
| AVNQALPVSNTHVKT | 756 | Q5VU36 | |
| LNIIQGEVDPTQVHK | 321 | P23258 | |
| QENSTLVVTLPHKVE | 651 | Q96N76 | |
| SKVQAAEHTLRNINP | 126 | Q9GZZ9 | |
| SIDLQAKHVPASAVV | 556 | Q9P227 | |
| IVEVFNKVLHSSNPV | 551 | Q92610 | |
| VSVEHQLSKPDVVSQ | 51 | Q96GC6 | |
| VSSVVVPLQQKFEIH | 351 | Q2MV58 | |
| ILPAAEHQTTSPVQK | 116 | Q7Z340 | |
| NTHSNVAVIPEKQLV | 2031 | O60281 | |
| QSVTEVNLPKEVHIG | 511 | Q9HCK1 | |
| HSVTNSPEVAVKKLN | 881 | Q9HCK1 | |
| HAQIPVVKTAAQSSL | 141 | Q9GZR1 | |
| TEALVNTAAKNQHPV | 2581 | O95359 | |
| FPTHVQVTVLQAKDL | 11 | Q7L804 | |
| QRQVVSHSADPKLVE | 66 | Q9BZZ2 | |
| NTGKIVVELPHSVNS | 361 | Q8N4Q0 | |
| ETHVNIINVEKPSIS | 476 | Q96NG8 | |
| IHQLDFVQVKASSPV | 426 | Q9C026 | |
| NSSVPLAEHLQIKEA | 1161 | Q9BZF9 | |
| LVHSAVDVPTIQEKV | 191 | Q15326 | |
| QVTQHARALVNPVKL | 3571 | Q7Z7G8 | |
| NRKAHLTDPQTAVIE | 346 | Q9Y2H8 | |
| PKQVFNVSHINISAL | 806 | Q6R2W3 | |
| LNIIQGEVDPTQVHK | 321 | Q9NRH3 | |
| VAVQKQISKAVHSNP | 1176 | Q6PGP7 | |
| NALPSHVKINVSRQT | 561 | Q9H0M0 | |
| PKHVQQTDVAATLAI | 306 | Q5H8A4 | |
| AAVDSLSHPAVNLKQ | 616 | Q9Y4E6 | |
| VQAIKTNLTDPDIHV | 676 | Q9Y4E6 | |
| ITHNPTNATLNKFIE | 21 | Q93096 | |
| NRIPKEITVSNIHQA | 1386 | Q9ULM3 | |
| NSVVISQLSHIPEDK | 486 | P49815 | |
| TRHSPTAFQNVIEKV | 676 | Q96C45 | |
| SQKASLHVVAVPQEK | 201 | Q86TJ5 | |
| SNAHVEDKVLASNPI | 186 | Q9NQX4 | |
| TPEIIHAQQVKNLSS | 6066 | P20929 |